The Mutational Profiles of EGFR 19 Exon Deletion and 21 Exon L858R Mutation and Their Association with Primary Response to EGFR-TKIs

被引：0
|
作者：
Liang, W. [1 ,2 ,3 ]
Li, C. [1 ,2 ,3 ]
Zhao, Y. [2 ,4 ,5 ]
He, J. [2 ,4 ,5 ]
机构：
[1] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
[2] China State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China
[3] Natl Clin Res Ctr Resp Dis, Guangzhou, Guangdong, Peoples R China
[4] Guangzhou Med Univ, Affiliated Hosp 1, Thorac Surg & Oncol, Guangzhou, Guangdong, Peoples R China
[5] Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
EGFR 19 Exon Deletion; EGFR 21 Exon L858R Mutation; Concomitant Mutations;
D O I：
10.1016/j.jtho.2018.08.442
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA15.05
引用
收藏
页码：S408 / S408
页数：1
相关论文
共 50 条
  • [1] Efficacy observation and prognosis analysis of EGFR-TKIs alone versus EGFR-TKIs plus chemotherapy in advanced lung adenocarcinoma with EGFR Exon 19 Deletion, Exon 21 L858R mutation: A historical cohort study
    Zhou, Jinhua
    Qin, Hongya
    Miao, Jianlong
    Liu, Ruijuan
    Wang, Wei
    [J]. MEDICINE, 2023, 102 (26) : E34110
  • [2] Concomitant Mutations in EGFR 19Del/L858R Mutation and Their Association with Response to EGFR-TKIs in NSCLC Patients
    Liang, Hengrui
    Li, Caichen
    Zhao, Yi
    Zhao, Shen
    Huang, Jun
    Cai, Xiuyu
    Cheng, Bo
    Xiong, Shan
    Li, Jianfu
    Wang, Wei
    Zhu, Changbin
    Li, Weiwei
    He, Jianxing
    Liang, Wenhua
    [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 8653 - 8662
  • [3] 3D radiomics predicts EGFR mutation, exon-19 deletion and exon-21 L858R mutation in lung adenocarcinoma
    Liu, Guixue
    Xu, Zhihan
    Ge, Yingqian
    Jiang, Beibei
    Groen, Harry
    Vliegenthart, Rozemarijn
    Xie, Xueqian
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (04) : 1212 - +
  • [4] Comparison of clinicopathologic characteristics between patients with EGFR exon 19 deletion and EGFR L858R mutation in lung cancer
    Chen, Zhen
    Zhang, Jing
    Huang, Ke
    Shen, Qian
    Teng, Xiaodong
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (09): : 4644 - 4649
  • [5] Association of mutant EGFR L858R and exon 19 concentration in circulating cell-free DNA using droplet digital PCR with response to EGFR-TKIs in NSCLC
    Zhu, Yan-Juan
    Zhang, Hai-Bo
    Liu, Yi-Hong
    Zhu, Ya-Zhen
    Chen, Jun
    Li, Yong
    Bai, Jian-Ping
    Liu, Li-Rong
    Qu, Yan-Chun
    Qu, Xin
    Chen, Xian
    Zheng, Guang-Juan
    [J]. ONCOLOGY LETTERS, 2017, 14 (02) : 2573 - 2579
  • [6] Cytoplasmic ERβ1 expression is associated with survival of patients with Stage IV lung adenocarcinoma and an EGFR mutation at exon 21 L858R subsequent to treatment with EGFR-TKIs
    He, Cheng
    He, Yifu
    Luo, Huiqin
    Zhang, Ming
    Wu, Jing
    He, Xiaofang
    Fu, Yuying
    Chen, Wenju
    Zou, Jinkun
    [J]. ONCOLOGY LETTERS, 2019, 18 (01) : 792 - 803
  • [7] Comparison of uncommon EGFR exon 21 L858R compound mutations with single mutation
    Peng, Liang
    Song, Zhigang
    Jiao, Shunchang
    [J]. ONCOTARGETS AND THERAPY, 2015, 8 : 905 - 910
  • [8] Comparison of EGFR L858R and EGFR E746-A750 Del Mutation-Specific Immunohistochemistry to EGFR Exon 19 and 21 Mutational Analysis by PCR in Primary and Metastatic Lung Adenocarcinomas
    Chabot-Richards, D.
    Buehler, K.
    Vasef, M. A.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 737 - 738
  • [9] Efficacy of pemetrexed for EGFR mutated lung carcinoma between L858R and Exon 19 deletion.
    Kogure, Yoshihito
    Saka, Hideo
    Oki, Masahide
    Kitagawa, Chiyoe
    Nakahata, Masashi
    Tsuboi, Rie
    Oka, Saori
    Hori, Kazumi
    Murakami, Yasushi
    Ise, Yuko
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] The complexity of EGFR exon 19 deletion and L858R mutant cells as assessed by proteomics, transcriptomics, and metabolomics
    Ochi, Nobuaki
    Takeyama, Masami
    Miyake, Noriko
    Fuchigami, Maki
    Yamane, Hiromichi
    Fukazawa, Takuya
    Nagasaki, Yasunari
    Kawahara, Tatsuyuki
    Nakanishi, Hidekazu
    Takigawa, Nagio
    [J]. EXPERIMENTAL CELL RESEARCH, 2023, 424 (01)
12345